• Infection Prevention and Control

Infection Prevention and Control

SUBMENÚ

 

 

Multi-resistant pathogens cause increases in healthcare costs due to the demand for more expensive drugs and prolonged hospital stays. Multi-resistant drugs are responsible for increased morbidity and mortality of patients admitted to hospitals. These hospital-acquired infections affect the most fragile patients in intensive care units; oncology and neonatology, which often result in high mortality.

1

IMPLEMENTATION OF HEALTH CARE-ASSOCIATED INFECTION PREVENTION AND CONTROL PROGRAMS: A ROAD MAP

This roadmap responds to a proposal by the Pan American Health Organization and is designed to support the countries of the Americas in the implementation of health care-associated infection prevention and control (HCPC) programs, in accordance with the WHO guidelines. (Available only in Spanish)


 

PDF Version web version

Guidelines, Technical Documents and Training Courses


 

Back to Menu

 

Latest news

Stories

Documents

Communication Materials

Epidemiological Updates and Alerts

Mandates and Strategies

Events